Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001404219-09-000017
Filing Date
2009-03-30
Accepted
2009-03-30 21:51:42
Documents
1
Period of Report
2009-03-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 20762
  Complete submission text file 0001404219-09-000017.txt   22528
Mailing Address 1 DNA WAY . SOUTH SAN FRANCISCO CA 94080
Business Address 1 DNA WAY SOUTH SAN FRANCISCO CA 94080 650-225-1000
GENENTECH INC (Issuer) CIK: 0000318771 (see all company filings)

EIN.: 942347624 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GENENTECH INC 1 DNA WAY MS 49 SOUTH SAN FRANCISCO CA 94080-4990
Business Address
EBERSMAN DAVID A (Reporting) CIK: 0001214123 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-09813 | Film No.: 09715803